التفاصيل البيبلوغرافية
| العنوان: |
Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study |
| المؤلفون: |
Randrian, V., Adenis, A., Desrame, J., Barbier, E., Di Fiore, F., Lievre, A., Dahan, L., Laurent-Puig, P., Mineur, L., Breysacher, G., Roquin, G., Louafi, S., Lopez, A., Louvet, C., Borg, C., Metges, J.-P., Faroux, R., Gaba, L., Manfredi, S., Tougeron, D. |
| المصدر: |
Annals of Oncology ; volume 30, page v324 ; ISSN 0923-7534 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2019 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: |
Oncology, Hematology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1093/annonc/mdz247.168 |
| الإتاحة: |
https://doi.org/10.1093/annonc/mdz247.168Test
https://api.elsevier.com/content/article/PII:S0923753419590573?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753419590573?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz247.168/30085940/mdz247.168.pdfTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: |
edsbas.4E7A9974 |
| قاعدة البيانات: |
BASE |
